NCT06000553Not yet recruiting
Early Detection of Pancreatic Cancer in Patients With Papillary and Mucinous Intracanal Tumours of the Pancreas Papillary and Mucinous Tumours of the Pancreas
Early Detection of Pancreatic Cancer in Patients With Papillary and Mucinous Intracanal Tumours of the Pancreas Papillary and Mucinous Tumours of the Pancreas PCS-IPMN-IPC 2023-005
Source: ClinicalTrials.gov · Last updated 21 Aug 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This trial is a prospective, exploratory and descriptive study. The primary objective is to identify early diagnostic biomarkers in patients with TIPMP based on the analysis of Treg lymphocyte subpopulations and epigenetic signatures, and the secondary objective is to characterize the biological processes underlying the transformation of a pre-neoplastic lesion into established ADPC.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 360 (estimated)
- First submitted
- 13 Jun 2023
- Start date
- 30 Oct 2023
- Primary completion date
- 30 Oct 2028
- Lead sponsor
- Institut Paoli-Calmettes
- Diseases
- Pancreatic cancer
- NCT number
- NCT06000553
What you commit to
- Study type: Interventional
- Planned participants: 360
- From 30 Oct 2023 to the primary completion date, 30 Oct 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Pregnant or breast-feeding woman
- Person in an emergency situation or unable to give consent.
- Adult subject to a legal protection measure (adult under guardianship, curatorship or safeguard of justice),
- Unable to undergo medical follow-up for geographical, social or psychological reasons.
- contraindication to MRI.
Who the study is looking for
- Age over 18
- Patient with intermediate-risk or high-risk TIPMP according to the European Study Group on Cystic Tumours of the Pancreas (3)
- Signed consent to participate
- Affiliation with a social security scheme, or beneficiary of such a scheme.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.